1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Israel >
  5. BiomX Acquires RondinX

M&A Deal Summary

BiomX Acquires RondinX

On December 19, 2017, BiomX acquired life science company RondinX

Acquisition Highlights
  • This is BiomX’s 1st transaction in the Life Science sector.
  • This is BiomX’s 1st transaction in Israel.

M&A Deal Summary
Date 2017-12-19
Target RondinX
Sector Life Science
Buyer(s) BiomX
Deal Type Add-on Acquisition

Target

RondinX

Tel Aviv, Israel
RondinX Ltd. is a drug discovery platform that develops solutions in the microbiome therapeutic and companion diagnostic spaces. RondinX Ltd. was established in 2015 and is based in Tel Aviv, Israel.

Search 215,029 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

BiomX

Ness Ziona, Israel
Category Company
Founded 2015
Sector Life Science
Employees52
DESCRIPTION

BiomX is a microbiome drug discovery company developing customized phage therapies that target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease (IBD) and cancer. BiomX was incorporated in 2015 and is based in Ness Ziona, Israel.

DEAL STATS #
Overall 1 of 3
Sector: Life Science M&A 1 of 2
Type: Add-on Acquisition M&A Deals 1 of 2
Country: Israel M&A 1 of 1
Year: 2017 M&A 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-10-28 CHAC

New York, New York, United States

CHAC is a special purpose acquisition company formed for the purpose of effecting a merger, acquisition, or similar business combination. CHAC was founded in 2017 and is based in New York, New York.

Buy -
Mergr

Solution for

Product

Company

Legal